1
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
Condition(s):SchizophreniaLast Updated:April 4, 2014Completed
RISPERDAL CONSTA: 202 Clinical Trials, Page 1 of 21
Hide Studies Not Open or Pending
2
Bioavailability of LY03004 and Risperdal® Consta®
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:March 4, 2015Completed
3
A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
Condition(s):Bipolar DisorderLast Updated:May 19, 2011Completed
4
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:June 24, 2014Completed
5
An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:June 18, 2015Completed
6
Bioequivalence Test for Risperdal 2mg of Janssen Korea
Condition(s):HealthyLast Updated:December 16, 2013Completed
7
Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:September 25, 2014Completed
8
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:September 18, 2015Completed
9
Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
Condition(s):SchizophreniaLast Updated:January 7, 2021Completed
10
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Condition(s):SchizophreniaLast Updated:July 19, 2013Completed